Artiva Biotherapeutics, Inc. (35) | Business Operations (7)
Browse by Subcategory
Recent Contracts
-
Amendment No. 1 to Strategic Collaboration Agreement, dated October 18, 2021, by and between the Registrant and Affimed GmbH
(Filed With SEC on December 16, 2021)
-
Form of Indemnification Agreement by and between the Registrant and its directors and officers
(Filed With SEC on April 8, 2021)
-
Master Agreement for Manufacturing Services, dated March 16, 2020, by and between the Registrant and Green Cross Cell Corporation
(Filed With SEC on April 8, 2021)
-
Amendment No. 1 to Master Agreement for Manufacturing Services, dated June 16, 2020, by and between the Registrant and Green Cross Cell Corporation
(Filed With SEC on April 8, 2021)
-
Master Research Services Agreement, dated August 3, 2020, by and between the Registrant and Green Cross LabCell Corporation
(Filed With SEC on April 8, 2021)
-
Exclusive License and Collaboration Agreement, dated January 27, 2021, by and between the Registrant and Merck Sharp & Dohme Corp
(Filed With SEC on April 8, 2021)
-
Strategic Collaboration Agreement, dated November 5, 2020, by and between the Company and Affimed GmbH
(Filed With SEC on April 8, 2021)